Resident T Cell Activation Leads to Human Hair Follicle Immune Privilege Loss Ex Vivo, Which Is Prevented by the DHODH Inhibitor Farudodstat: Relevance for Alopecia Areata

This study explores the role of resident T cell activation in the immune privilege collapse of hair follicles, a critical event in alopecia areata (AA). Using an ex vivo human hair follicle model, researchers found that T cell activation leads to increased MHC class I and II expression, indicating immune privilege loss. The DHODH inhibitor farudodstat was shown to reduce T cell proliferation and prevent this collapse, suggesting its potential as a therapeutic agent for AA. The study involved hair follicles from 7 healthy donors, providing a robust model for understanding AA pathogenesis and treatment. Further research is needed to optimize farudodstat treatment and compare its efficacy with existing therapies.